Topics

Sankyo Kasei Co., Ltd. Company Profile

16:36 EST 20th February 2020 | BioPortfolio

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 million
Capital increase: ¥50 million
Sodium hydrosulfide plant completed (Akitsu Plant)
Sodium sulfate plant completed (Mihara Plant)
Crystal sodium sulfide plant No.1 completed (Akitsu Plant)
Sodium hydrosulfide technical liquid plant (Kainan Work)
Crystal sodium sulfide plant No.2, and sodium sulfide plant completed (Akitsu Plant)
Capital increase: ¥90 million
Joint venture "Korea Sankyo Kasei Co." established.
Pharmaceutical intermediate "Guayacol" Plant completed (Mihara Plant)
Heavy metal remover "Santhiol" production started (5 related patents were filed in 14 countries)
Heavy metal remover "Santhiol" was awarded with the 22nd Industrial Technical Prize of Osaka Industrial Research Association
Reduction plant completed (Akitsu Plant)

Location

4-16, Dojimahama 1-Chome,Kita-ku
Osaka
530-0004
Japan

Contact

Phone: 81-6-6345-4138
Fax: 81-6-6345-4113


News Articles [129 Associated News Articles listed on BioPortfolio]

Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn

Japan-based Asahi Kasei, through its subsidiary Asahi Kasei Pharma Denmark, has offered to acquire Veloxis Pharmaceuticals in the US for...Read More... The post Asahi Kasei offers to buy Veloxis Pharm...

Asia Deal Watch: Daiichi Sankyo Obtains Brazilian Rights To Mitsubishi Tanabe’s ALS Drug

Daiichi Sankyo also gets right of first negotiation for edaravone, approved in the US and Japan, in other Central and...   

Asahi Kasei to acquire Veloxis Pharmaceuticals for $1.3bn

The Japanese conglomerate plans to acquire Veloxis Pharmaceuticals through its Danish subsidiary Asahi Kasei Pharma Denmark in a move to accelerate its transformation into a global healthcare company....

FDA Approves Daiichi Sankyo’s Turalio for the Treatment of TGCT, a Rare and Debilitating Tumor

Tokyo, Munich and Basking Ridge, NJ – (August 2, 2019) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration (FDA) approved TU...

Daiichi Sankyo reports positive data from hypercholesterolemia study

Daiichi Sankyo has reported findings from the Phase III clinical trial of bempedoic acid / ezetimibe fixed-dose combination (FDC) tablet...Read More... The post Daiichi Sankyo reports positive data fr...

Daiichi Sankyo Plays Long Game With Quizartinib Outside Japan

Japanese company Daiichi Sankyo has its eye on first-line FLT3-ITD AML indication after rejection of relapsed/refractory plans in EU and...   

Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute

The study is the first in the strategic oncology partnership announced between Daiichi Sankyo and Sarah Cannon, designed to expedite and optimize global clinical development of Daiichi Sankyo’s The...

Asahi Kasei offers to buy Veloxis

Asahi Kasei Corp. has offered to pay $0.88 (DKK6.00 each; a 5% premium) for publicly traded Veloxis Pharmaceuticals AS. The deal is valued at $1.31bn.

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Using a Non-Infectious MVM Surrogate For Assessing Viral Clearance During Downstream Process Development.

Viral contamination is an inherent risk during the manufacture of biopharmaceuticals. As such, biopharmaceutical companies must demonstrate the viral clearance efficacy of their downstream process ste...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan Medoxomil Tablets 40 mg and Benicar 40 mg Tablets of Daichi Sankyo Inc. USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan Medoxomil Tablets 40 mg and Benicar® 40 mg Tablets of Daiichi Sankyo Inc., USA. Dosing periods of studies were ...

BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets 40+10+25 mg and Tribenzor® 40+10+25 mg Tablets of Daichi ...

Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

Subjects to compare the single dose bioavailability of Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets 40+10+25 mg and Tribenzor® 40+10+25 mg Tablets of Daichi ...

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - D...

Companies [28 Associated Companies listed on BioPortfolio]

Sankyo Kasei Co., Ltd.

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant) ...

Asahi Kasei Pharma Corp.

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Pharma America

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Sankyo Co., Ltd.

Since Sankyo's founding, the Company has been continuously motivated by an unstinting drive to bring new pharmaceuticals to market. This introduction to Sankyo's progress to date will reveal the eager...

Asahi Kasei Corporation

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, con...

More Information about "Sankyo Kasei Co., Ltd." on BioPortfolio

We have published hundreds of Sankyo Kasei Co., Ltd. news stories on BioPortfolio along with dozens of Sankyo Kasei Co., Ltd. Clinical Trials and PubMed Articles about Sankyo Kasei Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sankyo Kasei Co., Ltd. Companies in our database. You can also find out about relevant Sankyo Kasei Co., Ltd. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record